332
Views
8
CrossRef citations to date
0
Altmetric
Reviews

Targeting CD28 to prevent transplant rejection

, MD FRCPC, , MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Melissa Y. Yeung, Steven Gabardi & Mohamed H. Sayegh. (2017) Use of polyclonal/monoclonal antibody therapies in transplantation. Expert Opinion on Biological Therapy 17:3, pages 339-352.
Read now

Articles from other publishers (7)

Farzana Yasmeen, Hana Seo, Nasir Javaid, Moon Suk Kim & Sangdun Choi. (2020) Therapeutic Interventions into Innate Immune Diseases by Means of Aptamers. Pharmaceutics 12:10, pages 955.
Crossref
Melissa Y. Yeung, Tanja Grimmig & Mohamed H. Sayegh. 2019. Co-signal Molecules in T Cell Activation. Co-signal Molecules in T Cell Activation 267 312 .
Piao-Ping Hu. (2016) Recent Advances in Aptamers Targeting Immune System. Inflammation 40:1, pages 295-302.
Crossref
Tong Zhu, James Keirns, Corrie Howieson, Atsunori Kaibara, Ronald Goldwater, Alan J. Kivitz, Vishala Chindalore, Stanley Cohen, Vicki Santos, Bolanle Akinlade, Robert Kernstock, Leticia Delgado-Herrera, Paul C Blahunka, Erik E. Karrer, Jay P. Garg, Nancy Samberg & Bernhardt G. Zeiher. (2016) Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients. Clinical Pharmacology in Drug Development 5:5, pages 408-425.
Crossref
Wenhui Zhang, Robert M. Kernstock, Erik E. Karrer, Stanley B. Cohen, Vishala L. Chindalore, Alan J. Kivitz, Paul C. Blahunka, Leticia Delgado-Herrera, Bernhardt G. Zeiher, Nancy L. Samberg & Jay P. Garg. (2016) A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy. Clinical Pharmacology in Drug Development 5:4, pages 259-268.
Crossref
Fei ChenChuming FanXuezhong GuHaixi ZhangQian LiuXiaoli GaoJie LuBaoli HeXun Lai. (2015) Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma. Medical Science Monitor 21, pages 2110-2115.
Crossref
Blagoje Soskic, Omar S. Qureshi, Tiezheng Hou & David M. Sansom. 2014. 95 136 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.